1
|
Calvo-Martín G, Plano D, Martínez-Sáez N, Aydillo C, Moreno E, Espuelas S, Sanmartín C. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments. Pharmaceuticals (Basel) 2022; 15:ph15121465. [PMID: 36558915 PMCID: PMC9780886 DOI: 10.3390/ph15121465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 11/20/2022] [Accepted: 11/22/2022] [Indexed: 11/29/2022] Open
Abstract
The norbornene scaffold has arisen as a promising structure in medicinal chemistry due to its possible therapeutic application in cancer treatment. The development of norbornene-based derivatives as potential chemotherapeutic agents is attracting significant attention. Here, we report an unprecedented review on the recent advances of investigations into the antitumoral efficacy of different compounds, including the abovementioned bicyclic scaffold in their structure, in combination with chemotherapeutic agents or forming metal complexes. The impact that structural modifications to these bicyclic compounds have on the antitumoral properties and the mechanisms by which these norbornene derivatives act are discussed in this review. In addition, the use of norbornene, and its related compounds, encapsulation in nanosystems for its use in cancer therapies is here detailed.
Collapse
Affiliation(s)
- Gorka Calvo-Martín
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
| | - Daniel Plano
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Correspondence: (D.P.); (C.A.); Tel.: +34-948425600 (ext. 806358) (D.P.); +34-948425600 (ext. 803183) (C.A.)
| | - Nuria Martínez-Sáez
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
| | - Carlos Aydillo
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Correspondence: (D.P.); (C.A.); Tel.: +34-948425600 (ext. 806358) (D.P.); +34-948425600 (ext. 803183) (C.A.)
| | - Esther Moreno
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
| | - Socorro Espuelas
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
| | - Carmen Sanmartín
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
| |
Collapse
|
2
|
Anju T, Preetha R, Shunmugam R, Mane SR, Arockiaraj J, Ganapathy S. Non-Clinical Investigation of Tuberculosis Drugs: Conjugated Norbornene-
Based Nanocarriers Toxic Impacts on Zebrafish. CURRENT NANOMEDICINE 2021; 11:224-236. [DOI: 10.2174/2468187312666211221130125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 11/24/2021] [Accepted: 12/08/2021] [Indexed: 10/16/2023]
Abstract
INTRODUCTION:
Rifampicin conjugated (R-CP), and rifampicin -isoniazid dual conjugated (RI-CP) norbornene-derived nanocarriers are newly designed for pH stimuli-responsive delivery of tuberculosis (TB) drugs. Its biosafety level is yet to be well established.
OBJECTIVES:
To assess the impacts of the nanocarriers on liver cells using zebrafish animal model and human liver cell line model (HepG2).
METHODS:
Initially, lethal dose concentration for the norbornene-derived nanocarrier systems in zebrafish was determined. The toxic effects were analysed at the sub-lethal drug concentration by histopathological study, total GSH level, gene expression and DNA damage in zebrafish liver cells. Fish erythrocyte nuclear abnormalities were also evaluated. Cell viability and oxidative stress level (ROS generation) after exposure to the nanoconjugates was determined using HepG2 cell in the in vitro study.
RESULTS:
In vivo studies of both R-CP and RI-CP showed 100% mortality at 96 hours for exposure concentration >100mg/l and showed toxic changes in zebrafish liver histology, GSH, and DNA damage levels. A noticeable upregulated PXR, CYP3A and cyp2p6 genes was observed in RI-CP exposure than in RIF or R-CP molecules. The in vitro study revealed a dose-dependent effect on cell viability and ROS generation for RIF, R-CP and RI-CP exposures in HepG2 cells.
CONCLUSION:
The current study reports that the rifampicin conjugated (R-CP) and rifampicin-isoniazid conjugated (RI-CP) norbornene derived nanocarriers exhibit enhanced toxic responses in both adult zebrafish and HepG2 cells. The pH-sensitive norbornene derived nanocarriers on conjugation with different drugs exhibited varied impacts on hepatic cells. Hence the present investigation recommends a complete metabolomics analysis and norbornene carrier-drug interaction study to be performed for each drug conjugated norbornene nanocarrier to ensure its biosafety.
Collapse
Affiliation(s)
- Thangammal Anju
- Department of Biotechnology and Department of Food Process Engineering, School of Bioengineering, SRM Institute
of Science Technology, Kattankulathur, 603 203, Chennai, Tamil Nadu, India
| | - Radhakrishnan Preetha
- Department of Biotechnology and Department of Food Process Engineering, School of Bioengineering, SRM Institute
of Science Technology, Kattankulathur, 603 203, Chennai, Tamil Nadu, India
| | - Raja Shunmugam
- Polymer Research Centre, Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata (IISER K), India
| | - Shivshankar R. Mane
- Polymer Research Centre, Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata (IISER K), India
| | - Jesu Arockiaraj
- Division of Fisheries
Biotechnology and Molecular Biology, Department of Biotechnology, Faculty of Science and Humanities, SRM
Institute of Science Technology, Kattankulathur, 603 203, Chennai, Tamil Nadu, India
| | - Shivasekar Ganapathy
- Department of Pathology,
SRM Medical college and research center, SRM Institute of Science Technology, Kattankulathur, 603 203, Chennai,
Tamil Nadu, India
| |
Collapse
|
3
|
Bochkarev LN, Parshina YP, Gracheva YV, Kovylina TA, Lermontova SA, Klapshina LG, Konev AN, Lopatin MA, Lukina MM, Komarova AD, Shcheslavskiy VI, Shirmanova MV. Red Light-Emitting Water-Soluble Luminescent Iridium-Containing Polynorbornenes: Synthesis, Characterization and Oxygen Sensing Properties in Biological Tissues In Vivo. Molecules 2021; 26:6349. [PMID: 34770757 PMCID: PMC8587708 DOI: 10.3390/molecules26216349] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Revised: 10/12/2021] [Accepted: 10/18/2021] [Indexed: 11/16/2022] Open
Abstract
New water-soluble polynorbornenes P1-P4 containing oligoether, amino acid groups and luminophoric complexes of iridium(III) were synthesized by ring-opening metathesis polymerization. The polymeric products in organic solvents and in water demonstrate intense photoluminescence in the red spectral region. The polymers P1 and P3 with 1-phenylisoquinoline cyclometalating ligands in iridium fragments reveal 4-6 fold higher emission quantum yields in solutions than those of P2 and P4 that contain iridium complexes with 1-(thien-2-yl)isoquinoline cyclometalating ligands. The emission parameters of P1-P4 in degassed solutions essentially differ from those in the aerated solutions showing oxygen-dependent quenching of phosphorescence. Biological testing of P1 and P3 demonstrates that the polymers do not penetrate into live cultured cancer cells and normal skin fibroblasts and do not possess cytotoxicity within the concentrations and time ranges reasonable for biological studies. In vivo, the polymers display longer phosphorescence lifetimes in mouse tumors than in muscle, as measured using phosphorescence lifetime imaging (PLIM), which correlates with tumor hypoxia. Therefore, preliminary evaluation of the synthesized polymers shows their suitability for noninvasive in vivo assessments of oxygen levels in biological tissues.
Collapse
Affiliation(s)
- Leonid N. Bochkarev
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Yulia P. Parshina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Yana V. Gracheva
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Tatyana A. Kovylina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Svetlana A. Lermontova
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Larisa G. Klapshina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Aleksey N. Konev
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Mikhail A. Lopatin
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Maria M. Lukina
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
| | - Anastasia D. Komarova
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
| | - Vladislav I. Shcheslavskiy
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
- Becker&Hickl GmbH, Nunsdorfer Ring 7-9, 12277 Berlin, Germany
| | - Marina V. Shirmanova
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
| |
Collapse
|
4
|
Huang J, Guo J, Zou X, Zhu J, Wu S, Zhang T. Bioinspired Heteromultivalent Chitosan- α-Fe₂O₃/Gadofullerene Hybrid Composite for Enhanced Antibiotic-Resistant Bacterial Pneumonia. J Biomed Nanotechnol 2021; 17:1217-1228. [PMID: 34167634 DOI: 10.1166/jbn.2021.3093] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Herein, we have designed and developed a heteromultivalent chitosan base α-Fe₂O₃/Gadofullerene (GdF) hybrid composite through a simple chemical precipitation method. Unlike other methods, the addition of external stabilizing agents to generate GdF nanoparticles (NPs) was not necessary herein. The prepared chitosan-α-Fe₂O₃/GdF hybrid nanocomposites were characterized using UV, FT-IR, XRD and morphological microscopic analyses. The results showed that α-Fe₂O₃ and GdF hybrid nanocomposites were successfully grown on the surface of chitosan. The FT-IR vibration peaks showed the formation of Fe₂O₃ NPs, and the vibration peak for Fe-O was 568 cm-1. The broad absorption peak observed in the range of 250-350 nm and a sharp absorption peak at 219 nm represents the UV absorption of the synthesized hybrid composites. XRD pattern showed sharp peaks of crystallinity and purity of α-Fe₂O₃ nanoparticles. Finally, the synthesized chitosan-α-Fe₂O₃/GdF hybrid composites were screened for their antibacterial resistance against the Escherichia coli, Pseudomonas aeruginosa, Bacilus subtilis, and Staphylococcus aereus. In addition, in vitro biocompatibility results exhibited that developed hybrid samples have provided high cell compatibility with fibroblast (L929) cell line. The in vivo bio inspired nanotherapeutics have the potential action to effective inhibition ability on antibiotic-resistant P. aeruginosa, which has been main factor of inducing pneumonia. In conclusion, we expect biomimicking systems combined with the effective antibacterial agent could be the suitable next generation therapeutic potential factors for prevention and treatment of antibiotic-resistant pneumonia.
Collapse
Affiliation(s)
- Jing Huang
- Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, and Institute of Respiratory Diseases, Guangzhou 510000, PR China
| | - Jiquan Guo
- Department of Pulmonary and Critical Care Medicine, Guangdon Provincial Peoples Hospital/Guangdon Academy of Medical Sciences/Guangdon Provincial Geriatrics Institute, Guangzhou 510000, PR China
| | - Xiaoling Zou
- Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, and Institute of Respiratory Diseases, Guangzhou 510000, PR China
| | - Jiaxin Zhu
- Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, and Institute of Respiratory Diseases, Guangzhou 510000, PR China
| | - Shaozhu Wu
- Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, and Institute of Respiratory Diseases, Guangzhou 510000, PR China
| | - Tiantuo Zhang
- Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, and Institute of Respiratory Diseases, Guangzhou 510000, PR China
| |
Collapse
|
5
|
Mondal S, Saha M, Ghosh M, Santra S, Khan MA, Das Saha K, Molla MR. Programmed supramolecular nanoassemblies: enhanced serum stability and cell specific triggered release of anti-cancer drugs. NANOSCALE ADVANCES 2019; 1:1571-1580. [PMID: 36132617 PMCID: PMC9418062 DOI: 10.1039/c9na00052f] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2019] [Accepted: 01/29/2019] [Indexed: 05/30/2023]
Abstract
A bolaamphiphilic cross-linked nanoassembly endowed with pH responsive degradation features has been designed and fabricated for stable noncovalent guest encapsulation and controlled release. The self-assembled bolaamphiphile is utilized to prepare cross-linked nanoassemblies to further stabilize the noncovalent guest encapsulation at a concentration below its critical aggregation concentration (CAC) in a large volume of water or serum for drug delivery applications. Thus, this system can simultaneously address premature drug release and safety issues. The nanoassemblies integrated with a β-thioester linker, which can be hydrolyzed selectively under mildly acidic conditions (pH ∼ 5.3) at a slow rate, thus enable controlled release of guest molecules. Biological evaluation revealed that doxorubicin loaded cross-linked nanoassemblies (CNs-DOX) are nontoxic to normal cells such as HEK-293 or PBMC, but in contrast, showed a robust apoptotic effect on colon cancer cells, HCT-116, indicating excellent specificity. Thus, the fabrication reproducibility, robust stability, triggered drug release and cell selective toxicity behavior make this small molecular system very promising in the field of chemotherapeutic applications.
Collapse
Affiliation(s)
- Sanchaita Mondal
- University of Calcutta, Department of Chemistry 92 APC Road Kolkata-700009 India
| | - Moumita Saha
- Cancer Biology and Inflammatory Disorder Division, Indian Institute of Chemical Biology 4, Raja S C Mullick Road Kolkata-700032 India
| | - Mousumi Ghosh
- University of Calcutta, Department of Chemistry 92 APC Road Kolkata-700009 India
| | - Subrata Santra
- University of Calcutta, Department of Chemistry 92 APC Road Kolkata-700009 India
| | - Mijan A Khan
- University of Calcutta, Department of Chemistry 92 APC Road Kolkata-700009 India
| | - Krishna Das Saha
- Cancer Biology and Inflammatory Disorder Division, Indian Institute of Chemical Biology 4, Raja S C Mullick Road Kolkata-700032 India
| | - Mijanur R Molla
- University of Calcutta, Department of Chemistry 92 APC Road Kolkata-700009 India
| |
Collapse
|
6
|
Antony R, Arun T, Manickam STD. A review on applications of chitosan-based Schiff bases. Int J Biol Macromol 2019; 129:615-633. [PMID: 30753877 DOI: 10.1016/j.ijbiomac.2019.02.047] [Citation(s) in RCA: 148] [Impact Index Per Article: 29.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 02/01/2019] [Accepted: 02/07/2019] [Indexed: 02/07/2023]
Abstract
Biopolymers have become very attractive as they are degradable, biocompatible, non-toxic and renewable. Due to the intrinsic reactive amino groups, chitosan is vibrant in the midst of other biopolymers. Using the versatility of these amino groups, various structural modifications have been accomplished on chitosan through certain chemical reactions. Chemical modification of chitosan via imine functionalization (RR'CNR″; R: alkyl/aryl, R': H/alkyl/aryl and R″: chitosan ring) is significant as it recommends the resultant chitosan-based Schiff bases (CSBs) for the important applications in the fields like biology, catalysis, sensors, water treatment, etc. CSBs are usually synthesized by the Schiff condensation reaction between chitosan's amino groups and carbonyl compounds with the removal of water molecules. In this review, we first introduce the available synthetic approaches for the preparation of CSBs. Then, we discuss the biological applications of CSBs including antimicrobial activity, anticancer activity, drug carrier ability, antioxidant activity and tissue engineering capacity. Successively, the applications of CSBs in other fields such as catalysis, adsorption and sensors are demonstrated.
Collapse
Affiliation(s)
- R Antony
- Centre for Scientific and Applied Research, PSN College of Engineering and Technology (Autonomous), Tirunelveli 627152, Tamil Nadu, India.
| | - T Arun
- Department of Chemistry, Kamaraj College, Thoothukudi 628003, Tamil Nadu, India
| | - S Theodore David Manickam
- Centre for Scientific and Applied Research, PSN College of Engineering and Technology (Autonomous), Tirunelveli 627152, Tamil Nadu, India.
| |
Collapse
|
7
|
Mukherjee S, Patra D, Dash TK, Chakraborty I, Bhattacharyya R, Senapati S, Shunmugam R. Design and synthesis of a dual imageable theranostic platinum prodrug for efficient cancer therapy. Polym Chem 2019. [DOI: 10.1039/c8py01535j] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Platinum-based chemotherapeutic agents are considered first-line treatments for various cancers but their application is limited by the lack of site specificity and severe side effects.
Collapse
Affiliation(s)
- Saikat Mukherjee
- Polymer Research Center
- Department of Chemical Sciences
- Indian Institute of Science Education and Research Kolkata
- Mohanpur-741246
- India
| | - Diptendu Patra
- Polymer Research Center
- Department of Chemical Sciences
- Indian Institute of Science Education and Research Kolkata
- Mohanpur-741246
- India
| | - Tapan K. Dash
- Polymer Research Center
- Department of Chemical Sciences
- Indian Institute of Science Education and Research Kolkata
- Mohanpur-741246
- India
| | - Ipsita Chakraborty
- Department of Physical Sciences
- Indian Institute of Science Education and Research Kolkata
- Mohanpur-741246
- India
| | - Rangeet Bhattacharyya
- Department of Physical Sciences
- Indian Institute of Science Education and Research Kolkata
- Mohanpur-741246
- India
| | - Shantibhusan Senapati
- Tumor Microenvironment and Animal Models Laboratory
- Department of Translational Research
- Institute of Life Sciences
- Bhubaneswar
- India
| | - Raja Shunmugam
- Polymer Research Center
- Department of Chemical Sciences
- Indian Institute of Science Education and Research Kolkata
- Mohanpur-741246
- India
| |
Collapse
|
8
|
|